Ohio State Comprehensive Weight Management Martha Morehouse Outpatient Care

Ohio State Comprehensive Weight Management at Martha Morehouse Outpatient Care operates as an academic weight management program within Ohio State Wexner Medical Center in Columbus, OH, staffed by fellowship-trained obesity medicine physicians who integrate peptide therapy with traditional metabolic interventions. The program addresses obesity, metabolic syndrome, type 2 diabetes, and related endocrine disorders through a multidisciplinary model that combines pharmacotherapy, metabolic testing, nutrition counseling, and behavioral medicine. Patients receive care from physicians board-certified in obesity medicine and endocrinology, supported by registered dietitians, exercise physiologists, and behavioral health specialists who coordinate treatment plans based on comprehensive metabolic assessments including resting metabolic rate testing, body composition analysis, and hormonal panels.

Ohio State Comprehensive Weight Management Martha Morehouse Outpatient Care offers a range of peptide therapy options tailored to individual patient needs. Treatment protocols are customized based on health goals, lab work, and medical history, with options for hormone optimization, metabolic health, tissue repair, and performance enhancement.

Physicians at the Martha Morehouse location hold faculty appointments at Ohio State University College of Medicine and maintain active research involvement in obesity pharmacotherapy and metabolic disease, bringing evidence-based protocols to clinical practice. The fellowship-trained obesity medicine specialists complete comprehensive evaluations that include medical history review, physical examination, laboratory assessment of thyroid function, cortisol levels, sex hormones, insulin resistance markers, and lipid profiles before designing peptide protocols. Patients with diabetes receive coordinated care between obesity medicine and endocrinology services, allowing for integrated management of glucose-lowering medications alongside peptides like Semaglutide or growth hormone secretagogues that affect insulin sensitivity. The academic setting provides access to clinical trials, advanced metabolic testing not widely available in community practices, and consultation with subspecialists in cardiology, hepatology, and reproductive endocrinology when metabolic disease affects multiple organ systems.

Patients begin with an initial consultation that includes metabolic testing, body composition analysis via DEXA scan or bioimpedance, and discussion of weight history, previous interventions, and treatment goals. The program structures care in phases: initial weight loss with intensive monitoring, transition to maintenance, and long-term follow-up with ongoing metabolic surveillance. Nutrition counseling sessions address macronutrient distribution, meal timing, and dietary patterns that support peptide therapy outcomes, while behavioral support targets eating behaviors, stress management, and sleep optimization. Patients using growth hormone secretagogues receive education on injection technique, timing relative to meals and exercise, and monitoring for side effects like water retention or changes in glucose metabolism. Those on Semaglutide follow titration schedules with regular check-ins to manage gastrointestinal effects and adjust dosing based on weight loss velocity and tolerance.

The Columbus location within Martha Morehouse Outpatient Care provides access to the full spectrum of Ohio State Wexner Medical Center resources, including bariatric surgery evaluation for patients who may benefit from combined surgical and medical approaches, endoscopic weight loss procedures, and specialized services for patients with obesity-related complications like non-alcoholic fatty liver disease or polycystic ovary syndrome. The program accepts referrals from primary care physicians throughout central Ohio and coordinates care with referring providers through shared electronic medical records and structured communication protocols. Patients benefit from the academic environment's emphasis on evidence-based practice, participation in national obesity medicine registries, and provider engagement with current research on peptide applications in metabolic disease. The clinic operates on a scheduled appointment basis with follow-up intervals determined by treatment intensity, typically ranging from biweekly visits during active weight loss to quarterly maintenance appointments, with telehealth options available for established patients requiring medication management or routine monitoring between in-person metabolic assessments.